-
-
-
-
-
-
-
Philip Morris International Urges U.S. Food and Drug Administration Advisory Committee to Recommend Continued Marketing of IQOS as Modified Risk Product
-
-
-
-
-
-
-
Philip Morris International Reports 2024 Third-Quarter & First Nine-Months Results; Raises 2024 Guidance for Reported Diluted EPS to $6.20 - $6.26 and Adjusted Diluted EPS to $6.45 - $6.51
-
-
-
-
-
-
-
Philip Morris International’s Swedish Match Affiliate Adding 450 Jobs with $232 Million Investment in Kentucky
-
-
-
-
-
-
-
Philip Morris International Presents at 2024 Deutsche Bank Global Consumer Conference
-
-
-
-
-
-
-
Philip Morris International Inc. Presents at 2023 Morgan Stanley Global Consumer & Retail Conference
-
-
-
-
-
-
-
Kaival Brands: Positioning for the Future
-
-
-
-
-
-
-
Philip Morris International Releases Integrated Report 2022
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

